Advancements in Stroke Care, Ischemic Stroke, and Cerebral Hemorrhages: Matthew Schrag, MD, PhD
September 26th 2023The associate professor of neurology at Vanderbilt University Medical Center discussed the progress in stroke care, focusing on ischemic strokes and cerebral hemorrhages, and their connection with vascular diseases and cognitive disorders. [WATCH TIME: 3 minutes]
The Complex Landscape of NMOSD and MOGAD-Associated Diseases: Erin Longbrake, MD, PhD
September 26th 2023The associate professor of neurology at Yale School of Medicine discussed the differentiation of neuromyelitis optica spectrum disorders and myelin oligodendrocyte glycoprotein -associated disease from multiple sclerosis at IFN 2023. [WATCH TIME: 5 minutes]
Promise in PACAP Pathway for Treating Migraine: Jessica Ailani, MD
September 25th 2023The director of the MedStar Georgetown Headache Center provided insight on the excitement behind PACAP, how it may offer an alternate way of treating migraine, and where research behind it currently stands. [WATCH TIME: 4 minutes]
The Future of Parkinson Disease Treatment With Innovative Wearable Devices: Alistair Mackett, MD
September 24th 2023The movement disorder specialist at Cambridge University Hospitals NHS Foundation Trust discussed the rise of wearable technology for managing Parkinson disease to potentially empower patients and monitor the disease at early stages. [WATCH TIME: 4 minutes]
Importance of Identifying Etiology in Pediatric Stroke: Kristin Guilliams, MD, MSCI
September 21st 2023The associate professor at Washington University School of Medicine provided commentary on the state of care for pediatric stroke, and the challenges with identifying the most likely etiology. [WATCH 3 minutes]
Shift in Treatment Paradigm for Dravet Syndrome: Joseph Sullivan, MD
September 21st 2023The director of the Pediatric Epilepsy Center at UCSF provided perspective on the advances in the treatment of Dravet syndrome, emerging research concepts in the field, and the influence of genetic testing. [WATCH TIME: 5 minutes]
Leading Efforts in Advancing Neurodevelopmental Disorder Research: Walter E. Kaufmann, MD
September 20th 2023The adjunct professor of human genetics at Emory University School of Medicine talked about efforts from various communities in neurological disorders, such as Rett syndrome, to develop new measures for research. [WATCH TIME: 3 minutes]
Introduction of Antisense Oligonucleotides to Treat Genetic Forms of Epilepsy: Joseph Sullivan, MD
September 18th 2023The director of the Pediatric Epilepsy Center at UCSF discussed STK-001, an antisense oligonucleotide in development for Dravet syndrome, and the promise behind this type of targeted approach. [WATCH TIME: 4 minutes]
Research Priorities for Advancing Care of Neuroimmune Disorders
September 16th 2023Sanford Siegel, Douglas Kerr, MD; and Benjamin Greenberg, MD, detailed the need for greater research on treatment strategies that repair myelin improve neurodegeneration, as well as expanded knowledge on how neuroimmune disorders present. [WATCH TIME: 5 minutes]
Need for Improving Epidemiologic Triggers of Rare Neuroimmune Disorders
September 15th 2023Benjamin Greenberg, MD; Douglas Kerr, MD; and Sanford Siegel provided perspectives on the gaps in the epidemiology and treatment paradigm for patients with rare neuroimmune disorders. [WATCH TIME: 3 minutes]
Complexities With Management and Treatment of Neuroimmune Disorders
September 14th 2023An expert neurology panel detailed some of the changes in therapeutic strategies and approaches to treating rare neuroimmune disorders, including the steps taken during the acute phase. [WATCH TIME: 6 minutes]